Anewsha Therapeutics Inc.
1 clinical trials · Sponsor
◉ Watch Anewsha Therapeutics Inc.
| Record | Firm | Date |
|---|---|---|
| (CBDRA60) to Prevent or Reduce Symptoms of COVID-19 and Prevention of Post-Acute Sequelae of SARS-CoV-2 Infection PASC (NCT04777981) | Anewsha Therapeutics Inc. | 2022-07-01 |
Track Anewsha Therapeutics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.